Avenue Therapeutics, Inc.
ATXI
$0.773
-$0.1725-18.24%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 2.60M | 4.92M | 3.19M | 1.78M | 161.00K |
Total Receivables | -- | -- | -- | -- | 13.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 28.00K | 69.00K | 116.00K | 67.00K | 18.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | 310.00K |
Total Current Assets | 2.63M | 4.99M | 3.31M | 1.85M | 502.00K |
|
|||||
Total Current Assets | 2.63M | 4.99M | 3.31M | 1.85M | 502.00K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 2.63M | 4.99M | 3.31M | 1.85M | 502.00K |
|
|||||
Total Accounts Payable | 657.00K | 592.00K | 662.00K | 401.00K | 560.00K |
Total Accrued Expenses | 287.00K | 522.00K | 337.00K | 209.00K | 1.16M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 29.00K | 47.00K | 413.00K | 586.00K | 3.30M |
Total Other Current Liabilities | 29.00K | 47.00K | 413.00K | 586.00K | 3.30M |
Total Current Liabilities | 973.00K | 1.16M | 1.41M | 1.20M | 5.02M |
|
|||||
Total Current Liabilities | 973.00K | 1.16M | 1.41M | 1.20M | 5.02M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 973.00K | 1.16M | 1.41M | 1.20M | 5.02M |
|
|||||
Common Stock & APIC | 103.65M | 102.72M | 98.10M | 92.51M | 87.92M |
Retained Earnings | -101.04M | -97.96M | -95.27M | -90.93M | -91.57M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 2.61M | 4.76M | 2.84M | 1.58M | -3.65M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 2.61M | 4.76M | 2.84M | 1.58M | -3.65M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -958.00K | -937.00K | -938.00K | -928.00K | -872.00K |
Total Equity | 1.65M | 3.83M | 1.90M | 654.00K | -4.52M |
|